The dyad gene is required for progression through female meiosis in Arabidopsis

In higher plants the gametophyte consists of a gamete in association with a small number of haploid cells, specialized for sexual reproduction. The female gametophyte or embryo sac, is contained within the ovule and develops from a single cell, the megaspore which is formed by meiosis of the megaspore mother cell. The dyad mutant of Arabidopsis, described herein, represents a novel class among female sterile mutants in plants, dyad ovules contain two large cells in place of an embryo sac. The two cells represent the products of a single division of the megaspore mother cell followed by an arrest in further development of the megaspore. We addressed the question of whether the division of the megaspore mother cell in the mutant was meiotic or mitotic by examining the expression of two markers that are normally expressed in the megaspore mother cell during meiosis. Our observations indicate that in dyad the megaspore mother cell enters but fails to complete meiosis, arresting at the end of meiosis 1 in the majority of ovules, This was corroborated by a direct observation of chromosome segregation during division of the megaspore mother cell, showing that the division is a reductional and not an equational one. In a minority of dqad ovules, the megaspore mother cell does not divide. Pollen development and male fertility in the mutant is normal, as is the rest of the ovule that surrounds the female gametophyte. The embryo sac is also shown to have an influence on the nucellus in wild type. The dyad mutation therefore specifically affects a function that is required in the female germ cell precursor for meiosis. The identification and analysis of mutants specifically affecting female meiosis is an initial step in understanding the molecular mechanisms underlying early events in the pathway of female reproductive development

A New Approach in Manufacturing of Reverse Vending Machine

Reverse vending machine is a concept or an idea which inculcate the habit of recycling the waste materials. Reverse vending machine will be working by taking recyclable waste into the machine and gives a use full thing as a token of appreciation. The aim of this project is to design and fabricate a reverse vending machine which takes recyclable waste into the machine and displays a token of appreciation. The machine can accept a plastic bottle of 90mm diameter without cap and tin cans can be accepted and crushed and stored. The machine has a capacity of storing 50 plastic bottles and 50 tin cans. There basically two parts, one is the mechanical part and the other is the electronics part. The mechanical part is used to crush the recyclable waste which is kept in the machine so that more plastic and cans can be recycled and stored. The electronics part which consist of sensor and microcontroller, is used to take the correct input and segregate the waste into its respective categories and give a token of appreciation as a LCD display. The whole system is automated by the help of electronics. Combining both parts will give a reverse vending machine. Reverse vending machine will be working by taking recyclable waste into the machine and gives a use full thing as a token of appreciation. With limited resources in the world, we need to start preserving them and put an end to wastage. Being encouraged to recycle through a rewards system.To encourage recycling process we are designing and manufacturing reverse vending machine

Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response.

BackgroundThis retrospective study aims to investigate the activity of retreatment with anti-EGFR-based therapies in order to explore the concept of clonal evolution by evaluating the impact of prior activity and intervening time interval.MethodsEighty-nine KRAS exon 2-wild-type metastatic colorectal patients were retreated on phase I/II clinical trials containing anti-EGFR therapies after progressing on prior cetuximab or panitumumab. Response on prior anti-EGFR therapy was defined retrospectively per physician-records as response or stable disease ≥6 months. Multivariable statistical methods included a multiple logistic regression model for response, and Cox proportional hazards model for progression-free survival.ResultsRetreatment anti-EGFR agents were cetuximab (n = 76) or cetuximab plus erlotinib (n = 13). The median interval time between prior and retreatment regimens was 4.57 months (range: 0.46-58.7). Patients who responded to the prior cetuximab or panitumumab were more likely to obtain clinical benefit to the retreatment compared to the non-responders in both univariate (p = 0.007) and multivariate analyses (OR: 3.38, 95 % CI: 1.27, 9.31, p = 0.019). The clinical benefit rate on retreatment also showed a marginally significant association with interval time between the two anti-EGFR based therapies (p = 0.053). Median progression-free survival on retreatment was increased in prior responders (4.9 months, 95 % CI: 3.6, 6.2) compared to prior non-responders (2.5 months, 95 % CI, 1.58, 3.42) in univariate (p = 0.064) and multivariate analysis (HR: 0.70, 95 % CI: 0.43-1.15, p = 0.156).ConclusionOur data lends support to the concept of clonal evolution, though the clinical impact appears less robust than previously reported. Further work to determine which patients benefit from retreatment post progression is needed

Measurements of the branching fractions of B+→ppK+ decays

The branching fractions of the decay B+ → pp̄K+ for different intermediate states are measured using data, corresponding to an integrated luminosity of 1.0 fb-1, collected by the LHCb experiment. The total branching fraction, its charmless component Mpp̄ < 2.85 GeV/c2 and the branching fractions via the resonant cc̄ states η c(1S) and ψ(2S) relative to the decay via a J/ψ intermediate state are [Equation not available: see fulltext.] Upper limits on the B + branching fractions into the η c(2S) meson and into the charmonium-like states X(3872) and X(3915) are also obtained

Impact of Pressure Biofeedback Analysis on Movement Control Exercise for Non-Specific Low Back Pain Treatment

Introduction: Low back pain in the class of prevalent musculoskeletal conditions, with almost 90% of cases classified as non-specific low back pain (NSLBP). Interestingly, the classification of mechanical low back pain (LBP) includes movement control deficits, specifically uncontrolled lumbo-pelvic movements, reflecting a deficit in controlling active movements in day-to-day life. The pressure biofeedback unit is accustomed to assess the functional stability of the trunk.Various traditional exercise protocols have been applied without making any sub-classifications. It is inappropriate to apply the same programs to all subjects with back pain. This study aims to identify the type of movement control impairments, assess them through a pressure biofeedback unit, and treat patients with corresponding movement control exercises tailored to their specific impairments.Aim: To ascertain the effect of movement control exercise (MCE) on NSLBP subjects using pressure biofeedback unit.Material and Methods: In this study, totally 40 subjects with non-specific low back pain (NSLBP) were selected. They were divided into two groups: an experimental group (Group A) and a control group (Group B), each consisting of 20 subjects, using proper randomization. Pre-test assessment was conducted using the movement control dysfunction test and a pressure biofeedback unit. Group A received treatment with movement control exercises, while Group B underwent spinal extension exercises and a back care program. Post-test assessment was carried out after the intervention. Results: The research study included 40 patients, with Group A comprising 20 patients receiving movement control exercises and Group B comprising 20 patients receiving spinal extension exercises. The results showed a reduction in pain, uncontrolled flexion, uncontrolled extension, and uncontrolled rotation patterns in both groups (p value, &lt;0.05). However, the comparison between Group A and Group B revealed that movement control exercises resulted in greater improvement than spinal extension exercises.Conclusion: Based on the findings, it can be concluded that movement control exercises are more effective than spinal extension exercises in treating NSLBP

Observation of the decay Bc→J/ψK+K−π+B_c \rightarrow J/\psi K^+ K^- \pi^+

The decay $B_c\rightarrow J/\psi K^+ K^- \pi^+$ is observed for the first time, using proton-proton collisions collected with the LHCb detector corresponding to an integrated luminosity of 3fb$^{-1}$. A signal yield of $78\pm14$ decays is reported with a significance of 6.2 standard deviations. The ratio of the branching fraction of \B_c \rightarrow J/\psi K^+ K^- \pi^+ decays to that of $B_c \rightarrow J/\psi \pi^+$ decays is measured to be $0.53\pm 0.10\pm0.05$, where the first uncertainty is statistical and the second is systematic.Comment: 18 pages, 2 figure

Study of B0(s)→K0Sh+h′− decays with first observation of B0s→K0SK±π∓ and B0s→K0Sπ+π−

A search for charmless three-body decays of B 0 and B0s mesons with a K0S meson in the final state is performed using the pp collision data, corresponding to an integrated luminosity of 1.0 fb−1, collected at a centre-of-mass energy of 7 TeV recorded by the LHCb experiment. Branching fractions of the B0(s)→K0Sh+h′− decay modes (h (′) = π, K), relative to the well measured B0→K0Sπ+π− decay, are obtained. First observation of the decay modes B0s→K0SK±π∓ and B0s→K0Sπ+π− and confirmation of the decay B0→K0SK±π∓ are reported. The following relative branching fraction measurements or limits are obtained B(B0→K0SK±π∓)B(B0→K0Sπ+π−)=0.128±0.017(stat.)±0.009(syst.), B(B0→K0SK+K−)B(B0→K0Sπ+π−)=0.385±0.031(stat.)±0.023(syst.), B(B0s→K0Sπ+π−)B(B0→K0Sπ+π−)=0.29±0.06(stat.)±0.03(syst.)±0.02(fs/fd), B(B0s→K0SK±π∓)B(B0→K0Sπ+π−)=1.48±0.12(stat.)±0.08(syst.)±0.12(fs/fd)B(B0s→K0SK+K−)B(B0→K0Sπ+π−)∈[0.004;0.068]at90%CL

Observation of the decay B+c→Bºsπ+

The result of a search for the decay B+c→Bºsπ+ is presented, using the Bºs→Ds-π+ and Bºs→J/ψϕ channels. The analysis is based on a data sample of pp collisions collected with the LHCb detector, corresponding to an integrated luminosity of 1  fb-1 taken at a center-of-mass energy of 7 TeV, and 2  fb-1 taken at 8 TeV. The decay B+c→Bºsπ+ is observed with significance in excess of 5 standard deviations independently in both decay channels. The measured product of the ratio of cross sections and branching fraction is [σ(Bc+)/σ(Bºs)]×B(Bc+→Bºsπ+)=[2.37±0.31 (stat)±0.11 (syst)-0.13+0.17(τBc+)]×10-3, in the pseudorapidity range 2<η(B)<5, where the first uncertainty is statistical, the second is systematic, and the third is due to the uncertainty on the Bc+ lifetime. This is the first observation of a B meson decaying to another B meson via the weak interaction